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Abstract
Background: A bacterial artificial chromosomal library of Planobispora rosea, a genetically intractable actinomycete 
strain, was constructed using Escherichia coli-Streptomyces artificial chromosome (ESAC) and screened for the presence 
of genes known to be involved in the biosynthesis of antibiotics.
Results: One clone with a 40 kb insert showed antimicrobial activity against Gram positive bacteria. Insert sequence 
analysis and subcloning experiments revealed that the bioactivity was due to a 3.5 kb DNA fragment containing two 
open reading frames. These orfs encode two proteins with high similarity to a putative membrane protein of 
Streptomyces coelicolor and to the nogalamycin resistance protein SnorO of Streptomyces nogalater, respectively. The 
role of these two Orfs is unknown in Planobispora. Disruption and complementation experiments revealed that both 
proteins are necessary for the antibacterial activity and chemical analysis demonstrated that the antibiotic activity was 
due to thiostrepton, antibiotic used as recombinant clone selection marker.
Conclusion: Two Planobispora rosea orfs are responsible for increasing intracellular amounts and storage of 
thiostrepton in Streptomyces lividans.
Background
Thiostrepton is a potent thiopeptide antibiotic, widely
used as a selection marker for thiostrepton-resistant (tsr)-
vectors in Streptomyces lividans but its routine use
revealed several unexpected biological activities.
Remarkably, it can induce resistance to antibiotics having
different cellular targets including daunorubicin, spar-
somycin, tetranactin and GE2270A [1] and causes expres-
sion of thiostrepton-induced proteins [2]. Two of these
thiostrepton-induced proteins, TipAL and TipAS, were
demonstrated to be alternative in-frame translation prod-
ucts of the tipA gene [3]. In particular, they share the C-
terminal region containing the binding domain for
thiostrepton and similar cyclic thiopeptide antibiotics [1].
Notwithstanding TipA was initially assigned as a
thiostrepton-induced activator of its own transcription
[1], its role has not been deeply understood yet. In fact,
tipA has been found to be present in many non-thiopep-
tide producing strains [4] and it is unclear what metabolic
signals are the genuine inducers of its expression.
Recently, it was established that thiostrepton is derived
from the precursor TsrA, a genetically encoded peptide,
suggesting that thiopeptide antibiotics are ribosomally
synthesized [5-8].
Heterologous expression systems were successfully
applied to synthesize metabolites, produced by hard-to-
manipulate strains [9]. Previous results [10-12] have
shown that E. coli-Streptomyces artificial chromosomes
(ESACs), carrying large inserts of actinomycete DNA,
can be introduced into a genetically accessible strain such
as  Streptomyces lividans, where they are stably main-
tained as an integrated form in its chromosome.
Planobispora rosea is a genetically intractable actino-
mycete producer of the thiazolylpeptide antibiotic
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GE2270, a potent inhibitor of the bacterial elongation fac-
tor Tu, which is structurally similar to thiostrepton [13].
In this paper we show that two P. rosea orfs, encoding a
membrane protein and an ABC transporter, when cloned
in Streptomyces lividans, determine thiostrepton uptake
and storage from thiostrepton-containing medium. This
has been experimentally shown by HPLC-ESI-mass spec-
trometry, HPLC-UV-DAD, feeding experiments with
13C-labeled cysteine and bioassays.
Results
Cloning and sequence analysis of a Planobispora rosea 40 
kb DNA fragment
Four clones of Streptomyces lividans, SL-40, -48, -85, -
120, isolated from a P. rosea genomic library [11], showed
antibacterial activity against M. luteus. Since SL-40,
which carried the smallest insert (40 Kb), was still able to
show antibacterial activity, this construct was used for the
subsequent investigations. Therefore, the insert was
sequenced (GenBank sequence accession number:
EU908202). The sequence analysis revealed thirty puta-
tive ORFs (Fig. 1a): ten hypothetical proteins, four puta-
tive regulators, six proteins related to membrane
transport (three ABC-transporters and three membrane
proteins), a chitinase, an isomerase, a xanthine dehydro-
genase, a terpene synthase, a Ser-Thr-kinase, a Tyr-Ser-
phosphatase, a gamma-glutamyltransferase, an acyl-CoA
dehydrogenase, a hydrolase and an oxidoreductase. Since
sequence analysis did not reveal the presence of any gene
assignable to an antibiotic biosynthesis pathway, different
fragments of the 40 kb insert were subcloned into the
ESAC vector and the obtained nine subclones were
repeatedly analysed for antibacterial activity against M.
luteus. Bioassay revealed that only one Streptomyces livi-
dans subclone, named SL-3.5 and carrying a 3.5 kb frag-
ment, showed antimicrobial activity. Furthermore, it was
found that SL-3.5 mycelium inhibited also the growth of
Bacillus subtilis, but not of Gram-negative bacteria, as E.
coli or Pseudomonas aeruginosa (data not shown). Swiss-
prot analysis of the insert sequence indicated that this
DNA fragment contained two divergently transcribed
orfs, named abc and imp. imp consists of 1023 bp and the
deduced product is a polypeptide consisting of 340 amino
acids with 50% similarity to a membrane protein of S. coe-
licolor (SCO5138). abc consists of 2430 bp and encodes a
protein of 809 amino acids that shows high levels of simi-
larity (80%) with an ABC-transporter of Streptomyces
nogalater involved in nogalamycin resistance (SnorO).
Both imp and abc are involved in antibacterial activity of 
SL-3.5
To investigate the role of Imp and Abc in stimulating
antibacterial activity in Streptomyces lividans, disruptants
containing solely imp  or  abc  were generated by inser-
tional inactivation and named SL-Imp and SL-Abc (Fig.
1b). Bioassays showed that the single knockout mutants
were not active against M. luteus, indicating that the
expression of both imp and abc is mandatory for antibac-
terial activity (Fig. 1c).
To confirm that the disruption of imp and abc genes
was the sole reason for the loss of antibacterial activity,
complementation mutants were generated and investi-
gated using the antibacterial assay. Our results indicated
that, comparably to SL-3.5, both complementation strains
had a high inhibitory activity on M. luteus (Fig. 1c).
The antibacterial activity of SL-3.5 is determined by 
thiostrepton
Streptomyces lividans ZX7 carries the actinorhodin,
undecylprodigiosin and calcium-dependent antibiotic
biosynthesis gene clusters in its genome, but they are pro-
duced only under particular nutritional conditions [14].
In the conditions we used (growth in R2YED for 4 days at
30°C) we did not detect any antibacterial activity of S. liv-
idans. To investigate if Planobispora proteins were able to
activate either act or red gene expression, spectrophoto-
metric assays of SL-40, SL-3.5 and control strain (SL-
ESAC) were carried out. Our results showed that the
amount of Act and Red produced from SL-40 and SL-3.5
was equal to those produced by S. lividans and SL-ESAC
(data not shown). Furthermore, SL-40 and SL-3.5 failed
to produce the calcium dependent antibiotic CDA.
To identify the antibacterial substance, dried methano-
lic extracts of SL-3.5 were extracted with a mixture of
water:acetone:ethyl acetate (1:1:1) and both phases ana-
lyzed by HPLC-ESI-MS analysis. The upper phase of SL-
3.5 extract contained a large peak (tR = 7.0 min) which
was absent in the SL-ESAC sample (data not shown). To
our surprise, the UV-spectrum as well as the molecular
mass ([M+H]+ = 1664.5 Da) identified the active sub-
stance as thiostrepton (data not shown). Comparison
with commercially available thiostrepton confirmed this
result. Moreover, TLC analysis revealed that also the
activity of SL-40 was exclusively due to thiostrepton (data
not shown).
SL-3.5 accumulates thiostrepton during antibiotic selection
As thiostrepton was used as selection marker for ESAC
containing  S. lividans strains and, at the time of this
work, the thiostrepton gene cluster had not been identi-
fied yet, two hypotheses arose from our results. The first
was the presence of silent thiostrepton biosynthetic genes
in S. lividans, whose expression was activated by Plano-
bispora proteins and the second one was the uptake and
storage of thiostrepton from the medium during SL-3.5
growth under selection pressure and its subsequent
release into thiostrepton-free medium.Giardina et al. Microbial Cell Factories 2010, 9:44
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To investigate whether a de novo thiostrepton synthesis
had occurred in S. lividans, we carried out feeding exper-
iments using isotopically labelled (R,S)-[3-14C]cysteine as
substrate. The radioactive samples were analyzed by TLC
followed by bioassay and autoradiographic analysis. The
bioassay clearly demonstrated that the inhibition halo
generated by SL-3.5 on M. luteus corresponded to the
TLC spot with Rf = 0.8, identical to that one of thiostrep-
ton produced from S. laurentii (Fig. 2a). However, the
autoradiographic analysis revealed that only the antibi-
otic produced by S. laurentii is radioactive (Fig. 2b).
Therefore, cysteine was not used by S. lividans as a sub-
strate for the biosynthesis of the previously identified
thiostrepton.
In a subsequent set of experiments we investigated if
the two P. rosea proteins, when present in SL-3.5, caused
the uptake of the thiostrepton used for strain selection.
Hence, we monitored the presence of the antibiotic in the
mycelial DMSO extracts of SL-3.5 after one (I), five (V)
and ten (X) passages of growth in thiostrepton-free
R2YED medium by antibacterial bioassay (Fig. 3a). In
addition, the same amount of each extract was spotted on
a cover glass and photographed under UV light, as
thiostrepton results luminescent (Fig.3b).
Thiostrepton was detected being released from SL-3.5
after passage I until passage V but could not be detected
after passage X. As a positive control S. laurentii extracts
were used and thiostrepton could always be detected
upon extraction. As a negative control SL-ESAC was
used, which was unable to take up and store thiostrepton.
All these results suggest that the thiostrepton is not
synthesized de novo from SL-3.5 but it is accumulated in
the cells from the thiostrepton-containing medium. The
detected antibacterial activity is due to the release of
thiostrepton during subsequent growth of SL-3.5 on
thiostrepton-free medium.
Figure 1 Sequence analysis of the SL-40 insert and Bioassay. a) Schematic diagram of sequence analysis of clone SL-40. Putative ORFs are indicat-
ed by the arrows; below is a list of the protein which each ORF is most similar to. The genes involved in SL-3.5 antibacterial activity are shown in grey 
and the remaining ORFs are in white. B indicates BamHI sites. b) Southern blot analysis of BamHI-digested total DNA isolated from SL-3.5 (lane 1), S. 
lividans (lane 2), P. rosea (lane 3), SL-ESAC (lane 4), SL-Abc (lane 5) and SL-Imp (lane 6). The BamHI fragment of 3.5 Kb (derived from digestion of ESAC3.5) 
was used as probe. c) Bioassay against Micrococcus luteus: 1) SL-40; 2) SL-ESAC; 3) SL-3.5; 4) SL-Abc; 5) SL-Abc/Imp; 6) SL-Imp and 7) SL-Imp/Abc.Giardina et al. Microbial Cell Factories 2010, 9:44
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Thiostrepton enters the cells in SL-3.5
To investigate whether thiostrepton was membrane-
bound or cytoplasmic, we analysed the expression level of
TipAS and the occurrence of TipAS-thio (thiostrepton-
bound TipAS) as Murakami et al. [3] demonstrated
thiostrepton activates tipA expression and binds TipAS.
Therefore, proteins extracted from SL-3.5 grown in pres-
ence or absence of thiostrepton for two passages in the
culture medium were analyzed by 2D-DIGE and com-
pared to the negative control SL-ESAC unable to store
thiostrepton (Fig. 4). As expected [15], our results
showed that expression of TipAS and TipAS-thio in the
negative control SL-ESAC is 10- and 7-fold higher in
presence of thiostrepton rather than in its absence. Inter-
estingly, the protein analysis revealed that TipAS and
TipAS-thio are 20- and 10-fold more expressed in SL-3.5
than in the negative control SL-ESAC grown in thiostrep-
ton absence. In addition, externally added thiostrepton
only slightly induced TipAS and TipAS-thio expression in
SL-3.5, suggesting that thiostrepton was already present
in the cells of SL-3.5 after the passage II in thiostrepton-
free R2YED medium.
Imp and Abc are involved in thiostrepton uptake
In order to test if Imp and Abc are involved in thiostrep-
ton uptake or secretion, we performed quantitative analy-
sis by HPLC/UV-DAD/ESI-MS of mycelium extracts of
SL-3.5, SL-Abc and SL-Imp after two passages in a
thiostrepton-free medium. HPLC ESI-MS analysis
revealed (Fig. 5) that both Orfs are essential for the
uptake of the antibiotic, in fact while negative control SL-
ESAC contained basically no antibiotic, SL-3.5 contained
up to 2 μg of thiostrepton per plate and the two mutants
SL-Abc and SL-Imp contained 0.07 and 0.05 μg per plate,
respectively. Our results suggest that Imp and Abc are
cooperatively involved in increasing the intracellular
thiostrepton amount.
Imp and Abc expression is medium-dependent and strain 
specific
When SL-3.5 strain was cultured in various liquid or solid
media different from R2YED (i.e. ONA), the antibiotic
activity was never detected (Fig. 6a and data not shown)
suggesting that the antibiotic effect could be medium-
dependent. Thus, we investigated whether imp and abc
genes were actively transcribed only in R2YED medium.
Quantitative RT-PCR experiments were performed using
total RNA extracted from SL-3.5 mycelium grown for 4
days on R2YED or ONA agar plates containing thiostrep-
ton. The results clearly demonstrated that both genes are
2,4-fold more transcribed in SL-3.5 when grown in
R2YED than in ONA (Fig. 6b). We can surmise that the
expression levels of imp  and  abc  were not enough to
determine the uptake of thiostrepton in ONA.
In addition, we investigated whether other streptomy-
cetes showed the same antibacterial effect when they
contained these two genes. To this aim, we transformed S.
coelicolor M145 with ESAC3.5, generating SC-3.5 strain.
Its capacity to uptake and maintain thiostrepton was
investigated by TLC analysis followed by bioassay of
extracts. The findings showed that SC-3.5 extract does
not contain thiostrepton (Fig. 6a). In accordance with this
result, we found that the transcription level of abc and
imp genes in SC-3.5 was lower than that of SL-3.5, even if
abc  transcription was 2-fold more induced in SC-3.5
grown in R2YED (Fig. 6b). All together these experiments
suggest that thiostrepton uptake is medium-dependent
and strain-specific.
Discussion
Heterologous expression in genetically and physiologi-
cally characterized hosts has been used as tool to access
the gene products of hard-to-manipulate strains [9].
Streptomyces species offer many potential advantages as
Figure 2 Feeding experiments. (a) Thin Layer Chromatography fol-
lowed by bioassays on M. luteus and (b) autoradiography showing ra-
dio-labeled thiostrepton (1); SL-ESAC (2), S. laurentii (3) and SL-3.5 (4) 
radioactive extracts. Solvent: acetone. Asterisks indicate the substance 
present in SL-ESAC and SL-3.5 that are not active and are different from 
thiostrepton.
Figure 3 Bioassay on M. luteus (a) and UV visualization (b): ex-
tracts were collected from SL-ESAC (1), SL-3.5 (2) and S. laurentii 
(3), grown for I, V or X passages in thiostrepton-free medium.Giardina et al. Microbial Cell Factories 2010, 9:44
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hosts for the heterologous expression of secondary
metabolite genes and we previously have successfully
demonstrated heterologous expression of actinomycete
genes in S. lividans [12].
At the beginning of this work, we were interested to
find new antibacterial activities against Gram-positive
bacteria by screening a Planobispora rosea ESAC library
in Streptomyces lividans [11]. In particular, we isolated
the clone SL-40 containing a P. rosea 40 kb fragment with
antibacterial activity against Gram-positive bacteria.
Sequencing and BLAST analysis of the insert revealed 30
genes not directly relatable to genes from secondary
metabolism biosynthesis. Finally, the sub-cloning
revealed that a 3.5 kb fragment encoding a membrane
protein (Imp) and an ABC transporter (Abc), whose role
is unknown in Planobispora, was attributed to the anti-
bacterial effects.
The presence of many cryptic or silent gene clusters in
Streptomycetes [16-18] on one hand and the evidence
that the two membrane proteins were both implicated in
the antibacterial activity on the other hand suggested that
the activity was due to an interaction between Plano-
bispora cloned genes and S. lividans genes.
Similar effects have been described by Rondon et al.
[19], who found that an antibacterial activity was deter-
mined by a membrane protein heterologously expressed
in E. coli from a metagenomic library and their results
Figure 4 Percentage volume of free and thiostrepton-bound TipAS forms. SL-ESAC and SL-3.5 strains were grown with thiostrepton (+ thio) and 
for II passages without thiostrepton (- thio).
Figure 5 HPLC analysis of thiostrepton: mycelium of SL-3.5 (1), 
SL-ESAC, (2), SL-Abc (3) and SL-Imp (4) grown for I passage with-
out thiostrepton. The total amount of thiostrepton in the myceli-
um is given in μg/plate.
Figure 6 The expression of imp and abc is medium-dependent 
and strain-specific. a) Thin Layer Chromatography followed by bioas-
says of thiostrepton (1); SL-ESAC (2), SL-3.5 (3), S. coelicolor (4), SC-3.5 (5) 
and S. laurentii (6) extracts. Solvent: acetone. Tester strain: M. luteus. b) 
qRT-PCR analysis of abc and imp transcription in SL-3.5 and SC-3.5 
grown on ONA (grey bars) and R2YED (black bars).Giardina et al. Microbial Cell Factories 2010, 9:44
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suggested that this protein caused an effect on the host
cell.
Unexpectedly, HPLC-ESI-mass spectrometry and
HPLC-UV-DAD unambiguously showed that the anti-
bacterial activity was due to thiostrepton, antibiotic used
for recombinant clones selection. Furthermore, our find-
ings revealed that a de novo thiostrepton synthesis had
not occurred in S. lividans (Fig. 2) but strongly suggested
that SL-3.5 antibacterial activity was caused by increased
intracellular amounts of thiostrepton (Fig. 4) and its sub-
sequent release in thiostrepton-free medium (Fig. 3). This
effect could be explained by an increased uptake of
thiostrepton from the medium, particularly triggered by
expression of Imp and Abc (in addition to a entry by dif-
fusion). imp and abc genes were found transcribed in a
medium-dependent manner in S. lividans; in fact, their
expression level was high enough to support the bioactiv-
ity only when the strain was grown in R2YED medium
(Fig. 6b). Further analyses have to be carried out to eluci-
date the biological mechanism.
In the course of our experiments, the thiostrepton bio-
synthetic cluster of the producer strain Streptomyces lau-
rentii  was sequenced [5] and its absence in the SL-3.5
strain was in agreement with our results (Fig. 2).
Although best known as an inhibitor of protein synthe-
sis, thiostrepton is also a potent activator of gene expres-
sion in Streptomyces lividans, i.e. it activates the
expression of the so-called thiostrepton-induced proteins
(TipAS and TipAL), whose role is still unknown. In the
absence of added cofactors, thiostrepton was reported to
form a highly stable complex with TipAL and TipAS in
aqueous solution, which cannot be dissociated by dena-
turants such as SDS, urea, or disulfide reducing agents
[20]. Our DIGE-analysis showed that large amounts of
thiostrepton enter the cell, induce TipA expression and
bind this protein, as demonstrated by the abundance of
TipAS and TipAS-thio in the mycelium grown also in the
absence of thiostrepton (Fig. 5). Thereby, the strain needs
t o  g r o w  f o r  m a n y  g e n e r a t i o n s  i n  a n  a n t i b i o t i c  f r e e
medium in order to dilute the thiostrepton intracellular
overstock in a appreciably way.
Moreover, the role of thiostrepton is not well under-
stood; it is hypothesized that active thiopeptides are not
only antibiotics but may serve as, or perhaps mimic, a sig-
nal molecule for physiological development or quorum-
sensing in bacteria [1]. It was suggested that antibiotics
are not only bacterial weapons for fighting competitors
but also signaling molecules that may regulate the
homeostasis of microbial communities [21]. For example,
didehydroamino acids of thiostrepton are highly reactive
toward low molecular weight thiols that maintain the
cytoplasmic redox potential [22] and it seems likely that
thiostrepton levels routinely used for selection of tsr-con-
taining vectors could reduce the concentrations of these
compounds and thereby disrupt overall cellular thiol-bal-
ance.
The expression of the two putative P. rosea membrane
proteins, responsible for increasing intracellular amounts
and storage of thiostrepton in S. lividans, causes a false
antibiotic production, that creates errors in the interpre-
tation of clone library screening results.
Our results showed that S. coelicolor containing imp
and abc does not uptake thiostrepton, probably since the
genes are transcribed at a low level (Fig. 6b). We can
speculate that in S. lividans Imp and Abc serve as recep-
tors or channels to up-take molecules such as thiostrep-
ton. Notwithstanding, further analyses are necessary to
investigate their role in P. rosea and in other heterologous
hosts, as well.
Conclusion
The heterologous gene expression has to be considered as
an useful biotechnological tool not only for new antibi-
otic discovery but also to study gene function in amena-
ble hosts. However, this work might result in the
reconsideration of a careful screening of a genomic
library directed to find new antibacterial substances
especially when genes encoding membrane proteins are
cloned and antibiotics with possible biological effects
interfering with the physiological activity of the host, as
thiostrepton, are used as clone selection markers.
Methods
Reagents
Thiostrepton was purchased from Fluka (Buchs, Switzer-
land).
Strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table 1. Micrococcus luteus and Bacillus subtilis
were used for bioassays. Four clones (SL-40, -85, -48 and -
120) were derived from an ESAC genomic library of P.
rosea [11]. S. lividans strains were cultured in the follow-
ing media: MG, JM, R2YED, ONA, TSB, Rare3 and R3
[14,23], according to Puglia et al. [24]. The SL clones were
selected using thiostrepton (50 μg ml-1).
Subcloning in E. coli and Streptomyces strains
Plasmid DNA, extracted from EC-40 by alkaline lysis
method [25] and digested with BamHI, was ligated to
BamHI-digested and dephosphorylated ESAC vector and
the ligation mixture was used to transform Escherichia
coli ElectroMAX DH10B cells, as described in Alduina et
al., 2005 [12]. Streptomyces protoplast formation, trans-
formation and regeneration were carried out according to
the methods of Kieser et al. [14]. Southern hybridization
was performed according to standard protocols [25].
DNA fra gme n ts used as pr obes w er e  la be ll ed wit h [ α-Giardina et al. Microbial Cell Factories 2010, 9:44
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32P]-CTP by the Rediprime II™ Random Prime Labelling
System (Amersham Pharmacia Biotech, UK).
Sequencing of the 40 kb DNA fragment from ESAC40
DNA sequencing was performed by MWG Biotech Labo-
ratories (Ebersberg, Germany). Open reading frame
(ORF) analysis was performed using Swiss prot protein
knowledge base. Putative orfs  were analyzed using
BLAST against the NCBI non redundant protein data-
base. The GenBank sequence accession number of the
Planobispora rosea 40 kb DNA fragment is EU908202.
Disruption of imp and abc
The imp and abc disruption mutants were obtained by
inserting pBluescript and pUC18 into the unique sites
ApaI and SacI site of ESAC3.5, respectively. The resulting
ESACabc and ESACimp plasmids were used to transform
S. lividans protoplasts, generating SL-Abc and SL-Imp
clones, respectively. Genomic DNA extracted from these
clones was digested with BamHI and analyzed by South-
ern hybridization using the 3.5 Kb BamHI fragment from
ESAC3.5, containing both orfs, as a probe. As expected,
two bands (6.5 and 6.2 Kb, respectively) were obtained for
Table 1: Strains and plasmids.
Strain/Plasmid Genotype/Description Source/Reference
Bacterial strains
Planobispora rosea ATCC53773 Biosearch Italia SpA, Gerenzano
Streptomyces lividans ZX7 pro-2 str-6 rec-46 Δdnd HAU3SLP2- SLP3- John Innes Centre, Norwich, UK
Streptomyces laurentii German Collection of Microorganisms and Cell 
Cultures, DSMZ GmbH, Braunschweig, Germany
Streptomyces coelicolor M145 John Innes Centre, Norwich, UK
Escherichia coli DH10B F- mcrA Δ(mrr- hsdRMS-mcr BC) Δ80dlacZDM15 
ΔlacX74 deoR recA1 endA1 araD139 Δ(ara, leu) 
7697 galU GalK D- rpsL nupG
Life Technologies, Gibco BRL.
EC-40 E. coli containing ESAC40 Alduina et al., 2003
SC-3.5 S. coelicolor containing ESAC3.5 This study
SL-ESAC S. lividans containing ESAC Alduina et al., 2003
SL-40 S. lividans containing ESAC40 Alduina et al., 2003
SL-3.5 S. lividans containing ESAC3.5 This study
SL-Abc S. lividans containing ESACAbc This study
SL-Imp S. lividans containing ESACImp This study
SL-Abc/Imp S. lividans containing ESACAbc and pNImp This study




ESAC Streptomyces-E. coli Artificial Chromosome Sosio et al., 2002
ESAC40 ESAC containing a P.rosea 40 kb fragment Alduina et al., 2003
ESAC3.5 ESAC containing a P.rosea 3.5 kb fragment with 
abc and imp genes
This study (fig.1)
ESACAbc ESAC3.5/imp::pBS This study (fig.1)
ESACImp ESAC3.5/abc::pUC This study (fig.1)
pN702GEM3 Fernández-Abalos et al., 2003
pNAbc pN702 containing abc This study
pNImp pN702 containing imp This studyGiardina et al. Microbial Cell Factories 2010, 9:44
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SL-Abc and SL-Imp (Fig. 1B, lane 5 and 6), while a 3.5 kb
band was obtained for SL-3.5 (Fig. 1B, lane 1).
Complementation of imp and abc mutations
A HindIII fragment containing imp and a BglII fragment
containing abc, derived from ESAC3.5, were ligated into
HindIII and BamHI sites of pN702GEM3 [26] to obtain
pNImp  and pNAbc  plasmids, respectively. These plas-
mids were introduced by protoplast transformation in
SL-Abc and SL-Imp to generate complementation
strains, isolated under apramycin selection (100 μg/ml-1).
Antibacterial assays and pre-purification of compounds
Antibacterial assays were carried out as follows: 5 ml of
LB soft agar containing 100 μl of M. luteus suspension in
water (OD600 of 1-1.2) were overlaid on LB agar plates.
R2YED plugs of S. lividans strains, grown for four days at
30°C, were put on the Micrococcus overlay. Plates were
then incubated overnight at 37°C and scored for activity
by looking for an inhibition zone in the M. luteus lawn.
The protocols reported in Hwang et al., 2003 [27] and
Adamis et al., 1990 [28] were used for the detection of
actinorhodin, undecylprodigiosin and calcium-depen-
dent antibiotic. To identify the antibiotic substance, the
methanolic extract of 20 agar plates for each analysed
strain was dried in vacuo and dissolved in 1 l of distilled
water. After XAD-chromatography (XAD-16 material,
300 ml column; 2 wash steps: 1 l H2O, 1 l 10% MeOH; elu-
tion with 500 ml acetone) and evaporation of the solvent,
the extract was dissolved in EtOAc/Acetone/H2O (1/1/1)
and both phases were analysed by HPLC-ESI-MS.
HPLC-ESI-mass spectrometry
HPLC-ESI-MS and HPLC-UV-DAD experiments were
carried out with a Q-Trap 2000 mass spectrometer from
Applied Biosystems Deutschland GmbH (Darmstadt,
Germany) (HPLC-ESI-MS), equipped with an 1100 series
capillary HPLC system (HPLC-ESI-MS) or a 1100 series
HPLC system (HPLC-UV-DAD) from Agilent Technolo-
gies Deutschland AG (Waldbronn, Germany) fitted with
a Luna 3u C18(2) 100 Å, 50 × 1 mm column (HPLC-ESI-
MS) or 50 × 4.5 mm column (HPLC-UV-DAD) pur-
chased from Phenomenex, Aschaffenburg, Germany.
Gradient 1: 25% B to 100% B in 10 min, gradient 2: 5% B
to 100%B in 10 min (A: water, HPLC-MS grade, 0.1% for-
mic acid, analytical grade; B: acetonitrile, HPLC-MS-
grade, 0.1% formic acid, analytical grade, all solvents were
purchased from Carl Roth GmbH & Co, Karlsruhe, Ger-
many).
The upper phase of SL-3.5 water:acetone:ethyl acetate
(1:1:1) extract contained a large peak in HPLC-ESI-MS
and HPLC-UV-DAD that was absent in SL-ESAC. Fur-
thermore, experiments confirmed its identity to
thiostrepton purchased from Fluka (data not shown).
Thiostrepton elutes at 7.0 min (HPLC-ESI-MS, gradient
1), 8.9 min (HPLC-ESI-MS, gradient 2) and 7.1 min
(HPLC-UV-DAD, gradient 2), respectively and has a
molecular mass of [M+H]+ = 1664.5.
Thin Layer Chromatography (TLC) and Feeding 
experiments
1 ml of pre-culture in JM medium of SL-ESAC, SL-3.5,
SC-3.5,  Streptomyces coelicolor and  S. laurentii were
streaked on R2YED medium and incubated at 30°C for
four days before freezing at -20°C. The frozen mixture
was added to 30 ml of methanol. An aliquot of 10-fold
concentrated methanol extract was extracted with a mix-
ture of water:acetone:ethyl acetate (1:1:1) and the upper
phase was analyzed by Thin Layer Chromatography
(TLC). TLC plates were developed in acetone and used
for the bioassay. 0.050 μg/μl of thiostrepton in water:ace-
tone:ethylacetate 1:1:1 were used as control.
In feeding experiments the isotopically labelled sub-
strate (R,S)-[3-14C]cysteine (30 μCi ml-1) was added to
R2YED medium and its presence in the extracts was
detected by autoradiographic exposition of the TLC plate
after acetone development.
Analysis of thiostrepton in the mycelium of SL-3.5
SL-3.5, S. laurentii (a thiostrepton producer, positive con-
trol) and SL-ESAC (negative control) were each grown on
R2YED agar plates containing thiostrepton (50μg/ml).
After 4 days mycelium from all the three strains was col-
lected and transferred to thiostrepton-free R2YED agar
plates (passage I). Mycelium from this passage was subse-
quently transferred to new thiostrepton-free R2YED agar
plates (passage II). This procedure was repeated 10 times.
To facilitate mycelium isolation, cellophane was placed
between the agar and the growing Streptomyces strains.
After passages I, V and X of each strain, 0.16-0.17 g of
mycelium were separated from agar and resuspended in 8
ml of distilled water. The suspension was sonicated three
times on ice (15 sec in Vibra cell-output control 4) and
the lysates were centrifuged for 10 min at 3000 r.p.m.
Thiostrepton present in the pellet was extracted using 2
ml of DMSO and 5 μl of this extract were analysed by bio-
assay on M. luteus and visualization using an UV lamp
(302 nm). The remaining solution was analyzed by
HPLC-ESI-MS: the samples were freeze-dried and dis-
solved in 200μl DMSO, centrifuged and 4μl of the clear
supernatant were injected into the HPLC-ESI mass spec-
trometer. The mass range during data acquisition was set
to  m/z  1600 - 1680 and the peak at tR = 8.9 min and
[M+H]+ = 1664,5 Da corresponding to thiostrepton was
integrated using the quantification tool in the MS-soft-
ware  Analyst 1.4.2 from Applied Biosystems. Prior to
thiostrepton quantification a calibration curve was estab-
lished using external samples of thiostrepton dissolved inGiardina et al. Microbial Cell Factories 2010, 9:44
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DMSO in 10 different concentrations between 0.05 μg/ml
and 20 μg/ml (y = 2332498.99 ×, R2 = 0.97).
Protein extraction, separation and analysis
Cells, grown as above, were recovered from cellophane
and protein extraction was performed as described previ-
ously [11]. Protein concentration was quantified using the
Qubit™ fluorometer (Invitrogen). After dialysis against
distilled water at 4°C and acetone precipitation at -20°C,
300 mg of extracted protein was resuspended in 50 ml of
lysis buffer (30 mM TRIS, 7 M urea, 2 M thiourea, 4%
CHAPS) to carry out Two-Dimensional Differential Gel
Electrophoresis (2D-DIGE, Amersham).
The pH of protein extracts was adjusted to 8.5 - 8.8 and
75 mg of proteins were labelled with CyDye DIGE fluors
(Cy3 for SL-3.5 grown with or without thiostrepton and
SL-Abc with thiostrepton; Cy5 for SL-ESAC with or with-
out thiostrepton and SL-Abc without thiostrepton),
according to the manufacturer's instruction. A pooled set
o f  i n t e r n a l  s t a n d a r d s ,  c o m p r i s i n g  2 5  m g  a l i q u o t  f r o m
each sample, was minimally labelled with Cy2 DIGE flu-
ors. After the labelling, rehydratation buffer was added to
obtain 350 μl (final volume) before IEF separation. Pro-
teins were first separated on 18 cm IPG strips (non-linear
gradient pH 3-10) in the ETTAN IPGphor isoelectric
focusing system. The IPG strips were rehydrated in IEF
buffer containing 0.5% (w/v) ampholytes and 1% (w/v)
bromophenol blue. For protein separation, a 30-V pre-
step was performed for 10 h, followed by IEF carried out
for 74,850 V-h with a maximum voltage of 8,000 V. All the
steps were performed at 20°C using 50 μA per strip. After
IEF, the IPG strips were saturated with an equilibration
buffer (6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 0.05
M TRIS-HCl pH 6.8 and 2% (w/v) DTE) for 12 min, in
order to resolubilize proteins. The thiol groups of Cys
were then blocked by substituting DTE with 2.5% (w/v)
iodoacetamide in the equilibrating buffer. The focused
proteins were then separated on 12% sodium dodecyl
polyacrylamide gels (SDS-PAGE) at 16°C in a Hoefer Dalt
vertical system, using a maximum setting of 40 μA and
110 V per gel. Two-dimensional gel analysis was per-
formed using the DIGE algorithms of ImageMaster 2D
platinum software (v. 6.01, GE Healthcare Biosciences)
according to the manufacturer's instructions. Spot detec-
tion was performed automatically using the auto-detec-
tion device. Spot quantification was calculated as the
volume of the spots (i.e. integration of optical density
over the spot area). Spot volumes were normalized (%Vol)
to the sum of the volume of all spots detected on each gel
by the software. To better visualize the results, the rela-
tive values were reported as %Vol × 100.
Total RNA isolation, RT-PCR analysis, and real-time RT-PCR
Collected mycelium of SL-3.5 and SC-3.5 grown on
R2YED and ONA agar plates was broken by using 1 mg of
lysozyme/ml in P-buffer and total RNA was extracted by
using the RNeasy midi-kit (QIAGEN) and following the
procedures reported in Alduina et al., 2007 [29]. As con-
trol of RNA quality, a reverse transcription-PCR (RT-
PCR) with 0.1 μg of total RNA and primer pairs internal
to  hrdB  (5'-cgtcgagggtcttcggctg-3' and 5'-cgcgagccca-
tctcgctgc-3') was carried out using a Superscript One-
Step RT-PCR kit (Invitrogen) and the conditions indi-
cated by the supplier. A negative control with Taq poly-
merase and without reverse transcriptase was included to
assess the absence of chromosomal DNA.
Expression of imp and abc was analyzed quantitatively
by real-time RT-PCR using the Applied Biosystems 7300
real-time PCR system (Applied Biosystems). Specific
primers internal to imp (5'-tgccagcgcgtacaggtgtcg-3' and
5'-cgcgggtcttggtctggctgt-3') and abc  (5'-cgtgcctggccct-
tcatcgac-3' and 5'-ggccctggcagatcatcgtgg-3') genes were
designed using the web-based tool GeneTool™ [30]. For
cDNA synthesis, 4 μg for each RNA were used as tem-
plate in a 50 μl reaction volume employing High Capacity
cDNA Archive Kit (Applied Biosystems, USA) according
to the manufacturer's instructions. PCR cycling was per-
formed at 25°C for 10 minutes, 37°C for 120 minutes and
then 5 minutes at 85°C.
2.5 μl of each sample were used in the quantitative PCR
reaction with SYBR® Green PCR Master Mix (Applied
Biosystems, USA) according to the manufacturer's
instructions. Each 25 μl reaction contained 10 pmol of
forward and reverse primers.
The PCR was performed under the following condi-
tions: 2 min at 50°C and 10 min at 95°C, followed by 40
cycles of 15 s at 95°C and 1 min at 60°C. Eventually, a dis-
sociation reaction was performed with the following con-
d i t i o n s :  a  1 - m i n  s t e p  w i t h  a  t e m p e r a t u r e  g r a d i e n t
increase of 1°C per step from 55 to 99°C. This last reac-
tion allowed the melting curve of the PCR products and,
consequently, to determine their specificity. A negative
control (distilled water) was included in all real-time PCR
assays, and each experiment was performed in triplicate.
The  hrdB  (5'-cgtcgagggtcttcggctg-3' and 5'-cgcgagccca-
tctcgctgc-3') gene was used as an internal control to
quantify the relative expression of target genes.
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